Literature DB >> 20526609

Initial results of trifocal diffractive IOL implantation.

Anna Voskresenskaya1, Nadezhda Pozdeyeva, Nicolay Pashtaev, Yevgeniy Batkov, Valeriy Treushnicov, Valentin Cherednik.   

Abstract

BACKGROUND: Bifocal intraocular lenses (IOL) are designed to reduce dependence on eyeglasses after surgery, but they cannot provide full range of vision, and have a drop of visual acuity in the intermediate distance. This problem may be solved with a trifocal lens, which produces three useful focal points. This study was conducted to evaluate clinical outcomes, functional vision and spectacle independence in patients with trifocal diffractive IOLs.
METHODS: Thirty-six eyes after implantation of diffractive intraocular lens MIOL-Record were evaluated. This IOL has a diffractive lens profile binary in phase and produces three useful foci. Outcome measures recorded 6 months postoperatively were uncorrected and distance-corrected (far, near, intermediate) visual acuities, contrast sensitivity (under photopic and mesopic condition), root-mean-square (RMS) of higher order aberrations (HOA), patients' quality of life (visual function questionnaire VFQ-25, halos and glare presence, overall satisfaction), and spectacle independence.
RESULTS: Postoperatively, monocularly, the uncorrected (UDVA) and the corrected distance visual acuity (CDVA) were 0.74 +/- 0.21 and 0.86 +/- 0.23 respectively (P < 0.05). No differences were found between uncorrected (UNVA)-0.85 +/- 0.13 and best distance-corrected near visual acuity (CNVA) 0.89 +/- 0.12 (P > 0.05). The uncorrected (UIVA) and best distance-corrected acuities of intermediate vision (CIVA) at 50 cm were 0.58 +/- 0.16 and 0.6 +/- 0.2 respectively. The photopic contrast sensitivity was within the standard normal range. But under dim light conditions it was inferior at all spatial frequencies by more than 0.2 logarithmic units. The mean aberration values were: total HOA RMS-0.816 +/- 0.362 mum, spherical aberration (SA)-0.207 +/- 0.136 mum, coma-0.335 +/- 0.206 mum. The percentage of patients achieving spectacle freedom was 94%. On the questionnaire, 25% of patient noted nighttime halos; glare difficulty was reported by 16.7% of patients, difficulties with night vision persisted in 22.3% of cases.
CONCLUSION: Diffractive trifocal intraocular lens MIOL-Record provided good uncorrected distance, intermediate and near vision, gave high rates of spectacle freedom and overall patient satisfaction.

Entities:  

Mesh:

Year:  2010        PMID: 20526609     DOI: 10.1007/s00417-010-1424-8

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  23 in total

1.  The effect of orientation learning on contrast sensitivity.

Authors:  N Matthews; Z Liu; N Qian
Journal:  Vision Res       Date:  2001-02       Impact factor: 1.886

2.  Visual performance of AcrySof ReSTOR apodized diffractive IOL: a prospective comparative trial.

Authors:  Carlos E Souza; Cristina Muccioli; Eduardo S Soriano; Maria Regina Chalita; Filipi Oliveira; Lincoln L Freitas; Luci P Meire; Celina Tamaki; Rubens Belfort
Journal:  Am J Ophthalmol       Date:  2006-03-20       Impact factor: 5.258

3.  Visual axial PSF of diffractive trifocal lenses.

Authors:  Pedro Valle; José Oti; Vidal Canales; Manuel Cagigal
Journal:  Opt Express       Date:  2005-04-04       Impact factor: 3.894

4.  [Comparison between OPD-Scan results and visual outcomes of Tecnis ZM900 and Restor SN60D3 diffractive multifocal intraocular lenses].

Authors:  Wilson Takashi Hida; Antonio Francisco Pimenta Motta; Newton Kara-José Júnior; Humberto Costa; Clayton Tokunaga; Livio Neiva Cordeiro; Daniela Gemperli; Celso Takashi Nakano
Journal:  Arq Bras Oftalmol       Date:  2008 Nov-Dec       Impact factor: 0.872

5.  Visual function after bilateral implantation of apodized diffractive aspheric multifocal intraocular lenses with a +3.0 D addition.

Authors:  Thomas Kohnen; Rudy Nuijts; Pierre Levy; Eduard Haefliger; José F Alfonso
Journal:  J Cataract Refract Surg       Date:  2009-12       Impact factor: 3.351

6.  Visual results following implantation of a refractive multifocal IOL in one eye and a diffractive multifocal IOL in the contralateral eye.

Authors:  Frank Joseph Goes
Journal:  J Refract Surg       Date:  2008-03       Impact factor: 3.573

7.  Visual performance with multifocal intraocular lenses: mesopic contrast sensitivity under distance and near conditions.

Authors:  Robert Montés-Micó; Enrique España; Inmaculada Bueno; W Neil Charman; José L Menezo
Journal:  Ophthalmology       Date:  2004-01       Impact factor: 12.079

8.  Prospective visual evaluation of apodized diffractive intraocular lenses.

Authors:  José F Alfonso; Luis Fernández-Vega; M Begoña Baamonde; Robert Montés-Micó
Journal:  J Cataract Refract Surg       Date:  2007-07       Impact factor: 3.351

9.  [Subjective and objective outcome following implantation of the apodized diffractive AcrySof ReSTOR].

Authors:  K Petermeier; P Szurman
Journal:  Ophthalmologe       Date:  2007-05       Impact factor: 1.059

10.  Dissatisfaction after multifocal intraocular lens implantation.

Authors:  Maria A Woodward; J Bradley Randleman; R Doyle Stulting
Journal:  J Cataract Refract Surg       Date:  2009-06       Impact factor: 3.351

View more
  23 in total

1.  Optical design and performance of a trifocal sinusoidal diffractive intraocular lens.

Authors:  Fidel Vega; Maite Valentino; Franco Rigato; María S Millán
Journal:  Biomed Opt Express       Date:  2021-05-12       Impact factor: 3.732

2.  Comparison of trifocal toric and bifocal toric intraocular lens implantation in patients with cataract and high corneal astigmatism.

Authors:  Merve Bozkurt Gencer; Hikmet Basmak; Erdogan Yasar; Ozkan Onal
Journal:  Int J Ophthalmol       Date:  2021-12-18       Impact factor: 1.779

3.  Postoperative visual performance with a bifocal and trifocal diffractive intraocular lens during a 1-year follow-up.

Authors:  Peter Mojzis; Lucia Kukuckova; Katarina Majerova; Peter Ziak; David P Piñero
Journal:  Int J Ophthalmol       Date:  2017-10-18       Impact factor: 1.779

4.  Trifocal intraocular lenses versus bifocal intraocular lenses after cataract extraction among participants with presbyopia.

Authors:  Diego Zamora-de La Cruz; Karla Zúñiga-Posselt; John Bartlett; Mario Gutierrez; Samuel A Abariga
Journal:  Cochrane Database Syst Rev       Date:  2020-06-18

5.  Visual outcomes after bilateral trifocal diffractive intraocular lens implantation.

Authors:  Jesús Carballo-Alvarez; Jose M Vazquez-Molini; Juan C Sanz-Fernandez; Javier Garcia-Bella; Vicente Polo; Julián García-Feijoo; Jose M Martinez-de-la-Casa
Journal:  BMC Ophthalmol       Date:  2015-03-14       Impact factor: 2.209

6.  Binocular function to increase visual outcome in patients implanted with a diffractive trifocal intraocular lens.

Authors:  Florian T A Kretz; Matthias Müller; Matthias Gerl; Ralf H Gerl; Gerd U Auffarth
Journal:  BMC Ophthalmol       Date:  2015-08-21       Impact factor: 2.209

7.  Visual performance after the implantation of a new trifocal intraocular lens.

Authors:  Jérôme C Vryghem; Steven Heireman
Journal:  Clin Ophthalmol       Date:  2013-10-01

8.  Visual and refractive outcomes after implantation of a fully diffractive trifocal lens.

Authors:  Béatrice Cochener; Jérome Vryghem; Pascal Rozot; Gilles Lesieur; Steven Heireman; Johan A Blanckaert; Emmanuel Van Acker; Sofie Ghekiere
Journal:  Clin Ophthalmol       Date:  2012-09-03

9.  Clinical Outcomes after Binocular Implantation of a New Trifocal Diffractive Intraocular Lens.

Authors:  Florian T A Kretz; Detlev Breyer; Vasilios F Diakonis; Karsten Klabe; Franziska Henke; Gerd U Auffarth; Hakan Kaymak
Journal:  J Ophthalmol       Date:  2015-08-02       Impact factor: 1.909

10.  Visual Performances of a New Extended Depth-of-Focus Intraocular Lens with a Refractive Design: A Prospective Study After Bilateral Implantation.

Authors:  Leopoldo Spadea; Maria Ilaria Giannico; Martina Formisano; Ludovico Alisi
Journal:  Ther Clin Risk Manag       Date:  2021-07-16       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.